The INTERNATIONAL JOURNAL OF NEUROSCIENCE, published by TAYLOR & FRANCIS LTD, stands as a vital resource in the field of neuroscience since its inception. With a proud history of publication from 1970 to 2024, this journal is committed to advancing knowledge in various domains of neuroscience, from fundamental research to clinical applications. It is indexed with an ISSN of 0020-7454 and an E-ISSN of 1563-5279, reflecting its wide reach and recognition. The journal maintains a respectable position in the academic landscape, categorized as Q2 in Medicine (miscellaneous) and Q3 in Neuroscience (miscellaneous) as of 2023, signifying its relevance among researchers and professionals. Although it currently does not offer open access, the journal remains a significant platform for disseminating groundbreaking research, thereby fostering collaboration and innovation within the neuroscience community. Located in the United Kingdom, the journal aims to bridge gaps in neuroscience knowledge, making it an essential reading for students, professionals, and researchers dedicated to unraveling the complexities of the nervous system.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.

NEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.

NEUROIMMUNOMODULATION is a well-respected journal published by KARGER that focuses on the intricate interactions of the nervous and immune systems. With its ISSN 1021-7401 and E-ISSN 1423-0216, it serves as a vital resource for researchers and professionals interested in neuroimmunology and related fields. The journal has been committed to disseminating high-quality research from its inception in 1994 and continues to thrive, with its scope converged until 2024. Notably, it holds a Q3 ranking in 2023 across diverse categories such as Endocrine and Autonomic Systems, Endocrinology, Immunology, and Neurology, reflecting its significance in the scientific community. Although the journal is not open access, it remains an essential publication for advancing knowledge and fostering collaboration among scholars, making it a noteworthy source of cutting-edge findings in the complex interplay between neural and immune processes.

The Journal of Brachial Plexus and Peripheral Nerve Injury, published by THIEME MEDICAL PUBL INC, is a leading open-access journal dedicated to the field of neurology, specifically focusing on injuries related to the brachial plexus and peripheral nerves. Since its inception in 2006, the journal has provided a platform for researchers, clinicians, and students to share cutting-edge studies and advancements within this specialized area of neurology. With an impact factor that underscores its relevance in the academic community, the journal is categorized in the Q4 quartile for both Neurology and Clinical Neurology in 2023. The journal aims to foster collaboration and innovation among professionals by presenting rigorous research findings, clinical studies, and reviews that enhance the understanding and management of nerve injuries. Published from the United Kingdom, the journal facilitates global access to important knowledge, encouraging contributions that will further the discourse in this critical field of medicine.

NEUROSCIENCE LETTERS is a distinguished journal published by ELSEVIER IRELAND LTD, focusing on disseminating impactful research across the field of neuroscience. With its ISSN 0304-3940 and E-ISSN 1872-7972, the journal serves as a vital platform for researchers, professionals, and students aiming to explore the complexities of nervous system function and related disorders. Since its inception in 1975, NEUROSCIENCE LETTERS has contributed significantly to the field, currently positioned in the Q3 category for Miscellaneous Neuroscience, with a respectable Scopus rank of 52/113, placing it in the 54th percentile among its peers. The journal is published in Ireland and offers a comprehensive repository of scientific insights, methodologies, and innovative findings that advance our understanding of neurological phenomena. While not an open-access journal, it remains an essential resource for the latest advances in neuroscience research and the academic community’s collective knowledge.

NEUROMODULATION is a premier academic journal dedicated to advancing the fields of anesthesiology, pain medicine, and neurology. Published by Elsevier, this prestigious journal has consistently maintained a high impact factor, reflecting its relevance and influence in the medical community. With a commendable track record spanning from 1998 to 2024, NEUROMODULATION is classified in the Q1 quartile for both Anesthesiology and Pain Medicine and Medicine (miscellaneous), demonstrating its excellence among top-tier journals. Additionally, it ranks in the Q2 quartile for Neurology and Clinical Neurology, showcasing a broad appeal across multiple disciplines. The journal's substantial Scopus rankings—22nd out of 136 in Anesthesiology and Pain Medicine and 93rd out of 400 in Clinical Neurology—underscore its critical role in disseminating cutting-edge research and clinical findings. NEUROMODULATION endeavors to provide a robust platform for researchers, clinicians, and students to explore innovative therapeutic approaches and the complexities of neural modulation, ultimately contributing to improved patient outcomes and advancing the state of medical science.

Neurology International is a prestigious open-access journal published by MDPI that has been making significant contributions to the field of neurology since its establishment in 2009. With its ISSN 2035-8377, this journal is committed to disseminating high-quality, peer-reviewed research that addresses a wide range of clinical topics in neurology. Operating out of Basel, Switzerland, the journal holds a respectable Q2 ranking in the clinical neurology category as of 2023, indicating its influence and dedication to advancing scientific knowledge. Researchers and practitioners alike will find value in its comprehensive articles, which are readily accessible to a global audience, facilitating the sharing of innovative findings and clinical practices. As it converges towards 2024, Neurology International continues to provide a vital platform for scholarly discourse, aiming to improve patient outcomes and enhance our understanding of neurological disorders.

Molecular and Cellular Pediatrics is a leading journal published by SPRINGERNATURE, dedicated to advancing knowledge in the fields of pediatrics, perinatology, and child health through innovative molecular and cellular research. Since its transition to Open Access in 2014, the journal has facilitated widespread dissemination of critical findings, making it accessible to a global audience of researchers, healthcare professionals, and students. The journal's scope encompasses a range of topics that explore the intersection of molecular biology and pediatric medicine, aiming to bridge gaps in our understanding of child health and development. With Scopus rankings placing it at the 48th percentile in pediatrics and a significant focus on cutting-edge research, Molecular and Cellular Pediatrics plays an essential role in shaping future research and clinical practices in the field. Its commitment to academic rigor and accessibility makes it a vital resource for those dedicated to improving pediatric health outcomes.

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.